González Crespo, María Rosa
Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. [artículo] - JAMA: The Journal of the American Medical Association, 2012 - 308(9):898-908.
Formato Vancouver:
López-Olivo MA, Tayar JH, Martínez-López JA, Pollono EN, Cueto JP, Gonzáles-Crespo MR,et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012 Sep 5;308(9):898-908.
PMID: 22948700
Contiene 110 referencias
CONTEXT: Concerns exist regarding the potential development of malignancies in patients with rheumatoid arthritis (RA) who are receiving biologic response modifiers (BRMs).
Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. [artículo] - JAMA: The Journal of the American Medical Association, 2012 - 308(9):898-908.
Formato Vancouver:
López-Olivo MA, Tayar JH, Martínez-López JA, Pollono EN, Cueto JP, Gonzáles-Crespo MR,et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012 Sep 5;308(9):898-908.
PMID: 22948700
Contiene 110 referencias
CONTEXT: Concerns exist regarding the potential development of malignancies in patients with rheumatoid arthritis (RA) who are receiving biologic response modifiers (BRMs).
